Please assess the completion status of the following clinical trial:

Trial Title: Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patient of any ethnic group~* Patient was at least 2-15 years old and suffered from mild to severe atopic dermatitis (Rajka/Langeland score of at least 3)~Exclusion Criteria:~* Patient had a genetic epidermal barrier defect such as Netherton's syndrome or generalised erythroderma~* Patient had a clinically significant skin infection on the affected (and to be treated) area

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 15 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).